Similar to HNSCC lines, treatment with A-485 generally led to more profound radiosensitization in CREBBP/EP300 mutant but not wild-type lung-cancer cell lines (Supplementary Fig. 6a, b). This evidence concerns the gene EP300 and lung carcinoma.